Literature DB >> 9730562

Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.

G Cerasola1, M Vecchi, G Mulè, S Cottone, M T Mangano, G Andronico, A Contorno, I Parrino, F Renda, G Pavone.   

Abstract

To study the potential role of sympathetic activity in the pathogenesis of arterial hypertension associated with autosomal dominant polycystic kidney disease (ADPKD) and to analyze its relationship with 24-hour blood pressure pattern, plasma catecholamines and 24-hour ambulatory blood pressure monitoring were evaluated in 30 ADPKD hypertensive patients (of which 17 without and 13 with renal failure) and in 50 essential hypertensives. The groups were matched for sex, body mass index, known duration of hypertension, and clinic blood pressure. Plasma catecholamines, determined in resting position, were higher in ADPKD patients without renal failure than in essential hypertensives. Nighttime diastolic blood pressure was higher and the percentage day-night difference in mean blood pressure was lower in hypertensives with ADPKD compared to patients with essential hypertension. Blood pressure was significantly correlated with plasma noradrenaline in ADPKD patients, independently of renal function. No significant differences were observed between ADPKD patients with and without renal failure, with respect to plasma catecholamines, 24-hour daytime and nighttime ambulatory blood pressures and the percentage day-night difference in mean blood pressure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730562     DOI: 10.1159/000013382

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  9 in total

Review 1.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  A case of cardiac compression by hepatic cyst in a woman with polycystic kidney disease.

Authors:  Maurizio Li Vecchi; Silvio Buscemi; Emilio Nardi; Vitalba Azzolina; Rossana Provenzano
Journal:  Intern Emerg Med       Date:  2008-02-07       Impact factor: 3.397

3.  Effects of CPAP on Blood Pressure and Sympathetic Activity in Patients With Diabetes Mellitus, Chronic Kidney Disease, and Resistant Hypertension.

Authors:  Marcel Ruzicka; Greg Knoll; Frans H H Leenen; Judith Leech; Shawn D Aaron; Swapnil Hiremath
Journal:  CJC Open       Date:  2020-03-27

4.  A young patient with a family history of hypertension.

Authors:  Aldo J Peixoto
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

Review 5.  The pathobiology of polycystic kidney disease from a metabolic viewpoint.

Authors:  Luis Fernando Menezes; Gregory G Germino
Journal:  Nat Rev Nephrol       Date:  2019-09-05       Impact factor: 28.314

Review 6.  Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?

Authors:  Stéphanie De Rechter; Luc Breysem; Djalila Mekahli
Journal:  Front Pediatr       Date:  2017-12-20       Impact factor: 3.418

Review 7.  Autosomal dominant polycystic kidney disease: updated perspectives.

Authors:  Anjay Rastogi; Khalid Mohammed Ameen; Maha Al-Baghdadi; Kelly Shaffer; Niloofar Nobakht; Mohammad Kamgar; Edgar V Lerma
Journal:  Ther Clin Risk Manag       Date:  2019-08-26       Impact factor: 2.423

Review 8.  [Sympathetic overactivity and the kidney].

Authors:  Antje Habicht; Bruno Watschinger
Journal:  Wien Klin Wochenschr       Date:  2003-09-30       Impact factor: 2.275

9.  New-onset Atrial Fibrillation is Associated With Polycystic Kidney Disease: A Nationwide Population-based Cohort Study.

Authors:  Tung-Min Yu; Ya-Wen Chuang; Mei-Ching Yu; Shih-Ting Huang; Che-Yi Chou; Cheng-Li Lin; Chun-Ching Chiu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.